[Benzimidazole derivative inhibition of the mutagenic activity of 2-aminoanthracene].
The antimutagenic activity of a new benzimidazole derivative that has antioxidative properties was found in the Salmonella/microsome test. This compound reduced the level histidine revertants induced by the promutagen and carcinogen 2-aminoanthracene. Inhibition of the mutagenicity of 2-aminoanthracene appears to be associated with the inactivation of its genotoxic metabolites. The capacity of the benzimidazole derivative for antimutagenic effects is possibly due to a dihydroxyphenyl radical that is present in its structure.